Oxbryta 72786-0111
Generic: Voxelotor
Product NDC
72786-0111- Manufacturer
- Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 17, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA216157
Need to source Oxbryta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Voxelotor | 300 mg/1 |
Drug Class
Hemoglobin S Polymerization Inhibitor [EPC]Cytochrome P450 3A4 Inhibitors [MoA]Hemoglobin S Polymerization Inhibitor [EPC]
Packaging Options(2)
60 TABLET, FOR SUSPENSION in 1 BOTTLE, PLASTIC (72786-111-02)
90 TABLET, FOR SUSPENSION in 1 BOTTLE, PLASTIC (72786-111-03)